A federal HIV vaccine trial that Vanderbilt University is being halted because of poor results. The nation’s most advanced clinical trial was stopped this week when an independent review discovered that more people who got a vaccine tested positive for HIV than those who received a placebo.
The trial involved 19 cities and had enrolled individuals marketed to people considered at high risk for contracting the virus.
Dr. Spyros Kalams is the principal investigator of the Vanderbilt HIV Vaccine Trials Unit. He told The Tennessean that the trial’s suspension “certainly tells us this approach is not the way to go.”
Vanderbilt is continuing with other HIV vaccine trials that are in earlier stages than the one that was just cancelled.
